523 related articles for article (PubMed ID: 32283177)
1. Coronavirus disease 2019 (COVID-19): first indication of efficacy of Gene-Eden-VIR/Novirin in SARS-CoV-2 infection.
Polansky H; Lori G
Int J Antimicrob Agents; 2020 Jun; 55(6):105971. PubMed ID: 32283177
[No Abstract] [Full Text] [Related]
2. Effects of Gene-Eden-VIR and Novirin on SARS-CoV: Implications for COVID-19.
Polansky H; Lori G
J Evid Based Integr Med; 2020; 25():2515690X20932523. PubMed ID: 32551855
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics to Predict Antiviral Drug Efficacy in COVID-19.
Migaud M; Gandotra S; Chand HS; Gillespie MN; Thannickal VJ; Langley RJ
Am J Respir Cell Mol Biol; 2020 Sep; 63(3):396-398. PubMed ID: 32574504
[No Abstract] [Full Text] [Related]
4. Human papillomavirus (HPV): systemic treatment with Gene-Eden-VIR/Novirin safely and effectively clears virus.
Polansky H; Itzkovitz E; Javaherian A
Drug Des Devel Ther; 2017; 11():575-583. PubMed ID: 28424535
[TBL] [Abstract][Full Text] [Related]
5. Chloroquine for COVID-19: rationale, facts, hopes.
Cortegiani A; Ippolito M; Ingoglia G; Einav S
Crit Care; 2020 May; 24(1):210. PubMed ID: 32384908
[No Abstract] [Full Text] [Related]
6. Investigating hypothiocyanite against SARS-CoV-2.
Cegolon L
Int J Hyg Environ Health; 2020 Jun; 227():113520. PubMed ID: 32305009
[No Abstract] [Full Text] [Related]
7. Considering mutational meltdown as a potential SARS-CoV-2 treatment strategy.
Jensen JD; Lynch M
Heredity (Edinb); 2020 May; 124(5):619-620. PubMed ID: 32251365
[No Abstract] [Full Text] [Related]
8. SARS-CoV-2 and COVID-19: What are our options? Where should we focus our attention on to find new drugs and strategies?
Magro G
Travel Med Infect Dis; 2020; 37():101685. PubMed ID: 32334088
[No Abstract] [Full Text] [Related]
9. Arguments in favour of remdesivir for treating SARS-CoV-2 infections.
Ko WC; Rolain JM; Lee NY; Chen PL; Huang CT; Lee PI; Hsueh PR
Int J Antimicrob Agents; 2020 Apr; 55(4):105933. PubMed ID: 32147516
[No Abstract] [Full Text] [Related]
10. The Good, the Bad, and the Hoax: When Publication Instantaneously Impacts Treatment Strategies for COVID-19.
Danion F; Ruch Y; Fourtage M; Kaeuffer C; Greigert V; Lefebvre N; Muller J; Nai T; Hansmann Y
Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32513798
[No Abstract] [Full Text] [Related]
11. [Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease?].
Nisole S; Saulnier A; Gatignol A
Virologie (Montrouge); 2020 Jun; 24(3):135-141. PubMed ID: 32648548
[No Abstract] [Full Text] [Related]
12. Sofosbuvir for COVID-19 infection: A potential candidate.
Gupta R; Dhamija P
Indian J Pharmacol; 2020; 52(3):232-233. PubMed ID: 32874010
[No Abstract] [Full Text] [Related]
13. Ivermectin, antiviral properties and COVID-19: a possible new mechanism of action.
Rizzo E
Naunyn Schmiedebergs Arch Pharmacol; 2020 Jul; 393(7):1153-1156. PubMed ID: 32462282
[TBL] [Abstract][Full Text] [Related]
14. Favipiravir, an antiviral for COVID-19?
Coomes EA; Haghbayan H
J Antimicrob Chemother; 2020 Jul; 75(7):2013-2014. PubMed ID: 32417899
[No Abstract] [Full Text] [Related]
15. Covid-19 and drug therapy, what we learned.
Provenzani A; Polidori P
Int J Clin Pharm; 2020 Jun; 42(3):833-836. PubMed ID: 32382873
[TBL] [Abstract][Full Text] [Related]
16. Famotidine Against SARS-CoV2: A Hope or Hype?
Ghosh R; Chatterjee S; Dubey S; Lavie CJ
Mayo Clin Proc; 2020 Aug; 95(8):1797-1799. PubMed ID: 32753153
[No Abstract] [Full Text] [Related]
17. Evaluation of Potential Therapeutic Options for COVID-19.
Austin D; Okour M
J Clin Pharmacol; 2020 Aug; 60(8):976-977. PubMed ID: 32469418
[No Abstract] [Full Text] [Related]
18. News Feature: To counter the pandemic, clinicians bank on repurposed drugs.
Madhusoodanan J
Proc Natl Acad Sci U S A; 2020 May; 117(20):10616-10620. PubMed ID: 32350142
[No Abstract] [Full Text] [Related]
19. Synergistic antiviral effects against SARS-CoV-2 by plant-based molecules.
Prasad A; Muthamilarasan M; Prasad M
Plant Cell Rep; 2020 Sep; 39(9):1109-1114. PubMed ID: 32561979
[TBL] [Abstract][Full Text] [Related]
20. Chloroquine and hydroxychloroquine in covid-19.
Ferner RE; Aronson JK
BMJ; 2020 Apr; 369():m1432. PubMed ID: 32269046
[No Abstract] [Full Text] [Related]
[Next] [New Search]
